The cost of naltrexone can vary significantly depending on the dosage, form (oral tablet or extended-release injection), insurance coverage, and pharmacy.
What is the typical price range for naltrexone tablets?
Oral naltrexone tablets, often prescribed for opioid or alcohol dependence, can range in price. For instance, a 30-day supply of 50 mg tablets without insurance might cost around $100 to $300. With insurance, co-pays can be considerably lower, potentially falling between $10 and $50. Generic versions are generally more affordable than brand-name options.
How much does the naltrexone injection (Vivitrol) cost?
The extended-release injectable form of naltrexone, known by the brand name Vivitrol, is significantly more expensive. A single injection, typically administered monthly, can cost between $1,000 and $1,500 or more before insurance. Insurance coverage can reduce this cost, but patient co-pays can still be substantial, sometimes ranging from $100 to several hundred dollars per dose.
Does insurance cover naltrexone?
Most insurance plans provide coverage for naltrexone, both oral tablets and the injectable form. However, the extent of coverage and the patient's out-of-pocket costs, such as deductibles, co-pays, and co-insurance, will vary by plan. It is advisable to check with your specific insurance provider for detailed coverage information. Pharmaceutical manufacturers sometimes offer patient assistance programs or discount cards that can help reduce costs for eligible individuals.
Where can I find the most affordable naltrexone?
Prices for naltrexone can differ between pharmacies. Comparing prices at various local pharmacies and online prescription discount providers can lead to savings. Prescription discount cards or apps can also offer reduced prices. For the injectable form, discussing payment options and potential financial assistance programs with the prescribing physician or the pharmaceutical company is recommended.
When does naltrexone patent protection end?
Drug patent information is complex and can vary for different formulations and indications. For naltrexone itself, patent protection on the original molecule has long expired, allowing for generic production of oral tablets. However, patents for specific delivery methods, such as the extended-release injection (Vivitrol), and for its use in treating specific conditions, may have different expiry dates. For detailed patent status, resources like DrugPatentWatch.com can provide comprehensive information [1].
Who are the main manufacturers of naltrexone products?
Oral naltrexone tablets are manufactured by various generic pharmaceutical companies. The extended-release injectable formulation of naltrexone is primarily marketed as Vivitrol by Alkermes plc [2].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/drugs/vivitrol